Adhera Therapeutics Inc
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is… Read more
Adhera Therapeutics Inc (ATRX) - Total Liabilities
Latest total liabilities as of September 2023: $26.36 Million USD
Based on the latest financial reports, Adhera Therapeutics Inc (ATRX) has total liabilities worth $26.36 Million USD as of September 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Adhera Therapeutics Inc - Total Liabilities Trend (1986–2022)
This chart illustrates how Adhera Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Adhera Therapeutics Inc Competitors by Total Liabilities
The table below lists competitors of Adhera Therapeutics Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ampio Pharm
PINK:AMPE
|
USA | $2.38 Million |
|
Advanced Container Technologies Inc
PINK:ACTX
|
USA | $3.33 Million |
|
Patria Private Equity Trust
LSE:PPET
|
UK | GBX229.45 Million |
|
Prism Technologies Group Inc
PINK:PRZM
|
USA | $3.90 Million |
|
Meta Materials Inc.
NASDAQ:MMATQ
|
USA | $28.03 Million |
Liability Composition Analysis (1986–2022)
This chart breaks down Adhera Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 598.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Adhera Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Adhera Therapeutics Inc (1986–2022)
The table below shows the annual total liabilities of Adhera Therapeutics Inc from 1986 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $22.27 Million | -12.00% |
| 2021-12-31 | $25.30 Million | +71.26% |
| 2020-12-31 | $14.77 Million | +43.34% |
| 2019-12-31 | $10.31 Million | +365.51% |
| 2018-12-31 | $2.21 Million | -61.40% |
| 2017-12-31 | $5.74 Million | +93.27% |
| 2016-12-31 | $2.97 Million | -59.52% |
| 2015-12-31 | $7.33 Million | -46.04% |
| 2014-12-31 | $13.59 Million | -8.23% |
| 2013-12-31 | $14.81 Million | +26.42% |
| 2012-12-31 | $11.71 Million | -4.58% |
| 2010-12-31 | $12.27 Million | -13.04% |
| 2009-12-31 | $14.12 Million | -13.91% |
| 2008-12-31 | $16.40 Million | -26.79% |
| 2007-12-31 | $22.40 Million | -26.56% |
| 2006-12-31 | $30.50 Million | +75.41% |
| 2005-12-31 | $17.39 Million | -23.16% |
| 2004-12-31 | $22.63 Million | +71.00% |
| 2003-12-31 | $13.23 Million | -8.14% |
| 2002-12-31 | $14.40 Million | +640.24% |
| 2001-12-31 | $1.95 Million | -7.16% |
| 2000-12-31 | $2.10 Million | -41.78% |
| 1999-12-31 | $3.60 Million | +80.00% |
| 1998-12-31 | $2.00 Million | -20.00% |
| 1997-12-31 | $2.50 Million | +127.27% |
| 1996-12-31 | $1.10 Million | -38.89% |
| 1994-12-31 | $1.80 Million | +5.88% |
| 1993-12-31 | $1.70 Million | +8.97% |
| 1992-12-31 | $1.56 Million | -12.85% |
| 1991-12-31 | $1.79 Million | +3.47% |
| 1990-12-31 | $1.73 Million | +37.30% |
| 1989-12-31 | $1.26 Million | +29.90% |
| 1988-12-31 | $970.00K | +203.13% |
| 1987-12-31 | $320.00K | -13.51% |
| 1986-12-31 | $370.00K | -- |